Introduction
Atherosclerosis is a chronic inflammatory disease influenced by circulating cells, including platelets 1 . Endothelial dysfunction, an early event in this process, leads to platelet adhesion, which in turn leads to several steps in the development of atherosclerosis, including leukocyte infiltration 2 . Furthermore, inhibition of platelet adhesion reduces leukocyte accumulation and leukocyte migration 16 . Thus, the platelet releasate contains factors of major significance in the development of atherothrombosis. Here, we employed a comprehensive proteomics approach to isolate, separate and identify the contents of the platelet releasate, a fraction highly enriched for platelet granular and exosomal contents, and we demonstrate the presence of several of these proteins in human atherosclerotic lesions.
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For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From blocked slides for the indicated time prior to fixation for 7 minutes in ice-cold methanol. Slides were then permeabilized in ice-cold acetone for 2 minutes and blocked with normal goat serum or BSA at room temperature for 30 minutes. The slides were incubated with primary antibody (antibodies as for western blotting) for 45 minutes and then a fluorescent secondary antibody (Alexa 488-conjugated goat anti-rabbit or mouse anti-goat) for 10 minutes. These slides were visualised using an argon laser at 488 nm. For dual stained images, the slides were incubated with anti-CD41 monoclonal antibody (IgG1; clone SZ22; Beckman Coulter, Buckinghamshire, UK) for an additional 45 minutes and then a fluorescent Alexa 546-conjugated goat anti-mouse secondary for 10 minutes. Control procedures included unstained cells to allow for only.
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Immunohistochemistry
Samples of arterial tissue were obtained from patients with atherosclerosis at the time of surgery for carotid or peripheral vascular disease (n=5) and fixed in formal saline for immunohistochemistry analysis 26 . The study was approved by the Irish Medicines Board and the Ethics Committee of Beaumont Hospital, Dublin, and all patients gave written informed consent. All patients were undergoing surgical revascularization for peripheral vascular disease or carotid endarterectomy. Normal arterial sections were obtained from young individuals who had no gross or microscopic evidence of atherosclerosis. Sections (5 µm) were stained with hematoxylin and eosin and for proteins of interest, as described previously 26 . Primary antibodies were as for western blotting and confocal microscopy. Anti-rabbit platelet factor 4 (PF4) polyclonal antibody (Ab1488P) was from Chemicon International (Temecula, California). Monoclonal anti-smooth muscle actin (mouse IgG2a isotype) was purchased from Sigma Aldrich, Tallaght, Ireland 26 .
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Results
Platelets were isolated by differential centrifugation and stimulated with 0.5 Units/ml thrombin for 3 minutes to achieve maximum release of all granule contents (alpha, dense and lysosomal) 27 . It is expected that the secretion profile of platelets would change depending on the agonist, although this may be more quantitative than qualitative. In order to visualize the proteins released from thrombin-activated platelets, the releasate fraction was harvested by centrifugation and separated using one-dimensional SDS-PAGE. A considerably higher concentration of protein was found in the thrombin-activated sample, particularly between the molecular weights of 5-15kDa, 30-50kDa and 120-180kDa ( Figure 1a ). Western blot analysis demonstrated thrombospondin (p10), a known secreted protein, only in the activated releasate lane (Fig. 1b) . Flow cytometry for P-selectin (CD62), an -granule marker protein, showed a 3-fold increase in platelet expression following treatment with thrombin, indicative of -granule membrane fusion and exocytosis. Western blotting for the signalling protein FAK (focal adhesion kinase) and the membrane protein IIb were performed on platelet lysates and platelet supernatant fractions. These proteins were not found in the platelet supernatant fractions indicating that platelet cell lysis had not occurred and microvesicles were not present in the preparation (data not shown).
Twenty-two protein spots were excised and digested with trypsin following two-dimensional (2-D) gel electrophoresis of the activated platelet releasate and staining with Coomassie Blue.
The resulting peptides were analysed by MALDI-TOF MS and the proteins identified using
Mascot. The identifications were accepted if they represented the highest-ranking hit, had MOWSE scores over 64, and if the sequence coverage was at least 15-30% (depending on protein size) 28 . The protein identities, sequence coverage and MOWSE probability scores obtained for the each of the 22 spots are detailed in Table 1 and Figure 2 . Nine different proteins were identified from the 22 spots, several being isomeric forms of the same protein (Fig. 2) .
We then used multidimensional liquid chromatography coupled with electrospray MS to further characterize the platelet releasate. The released protein fraction from thrombin-activated platelets was digested with trypsin and the resulting peptides loaded under pressure on to a nanocapillary column containing both strong cation exchange and reverse phase materials 29 .
Seven successive salt elutions and HPLC cycles were used to separate the peptides (Fig. 3a-g ).
The thrombin-activated releasates of pooled donors were analysed using identical cycle conditions in three independent experiments. Over 300 proteins were identified, with 81 observed in two or three experiments (Table 2 ). Seventy percent of these 81 were identified in all three experiments. Reproducibility of identification for a repeat analysis of a single sample was 80%. This suggests that 20% of the variation in the results arise from missed identifications due to saturation of the MudPIT analysis, while 10% may represent donor-todonor variation.
37% of the proteins identified were previously reported to be released from platelets including Table 2 ).
We focused on three proteins, secretogranin III (SgIII), cyclophilin A and calumenin, which are not known to be present in or released from platelets. SgIII (Fig. 4c ), cyclophilin A ( Fig. 4b) and calumenin ( Fig. 4a) were found by western blot in resting (PC) and thrombin activated platelet lysates (PA), as well as in the supernatant of thrombin-activated platelets (RA) (Fig. 4) .
Neither SgIII nor calumenin were detected in a crude leukocyte lysate (WBC), although only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From cyclophilin A was present in low amounts (Fig. 4) . These three proteins were identified in Pselectin positive platelets by flow cytometry (data not shown) and in CD41 positive platelets adhering to fibrinogen-coated slides using confocal microscopy ( Fig. 5b) . No staining was observed in platelets stained for secondary antibody only (Fig. 5c ).
Sections of arterial tissue from five patients with atherosclerosis were examined using immunohistochemistry 26 . The results from a representative patient are shown (Fig. 6 ). Low power H & E staining of normal (a) and atherosclerotic plaque (h) are provided for orientation of these sections. Atherosclerotic but not normal artery stained for the platelet specific proteins PF4 (Fig. 6j) and CD41 (Fig. 6i) . SgIII (Fig. 6l) and calumenin (Fig. 6m) were also expressed widely in the plaque, while vascular smooth muscle cells in the lesion, identified by staining for actin (6g,n), stained for cyclophilin A (Fig. 6k) . None of the proteins were found in normal artery ( Fig. 6b-f 
Discussion
We identified over 300 proteins in the platelet releasate; a fraction highly enriched for platelet granular and exosomal contents. This list included proteins of relatively low (e.g., thrombospondin) and high (e.g., platelet glycoprotein V) isoelectric point, as well as low (e.g., PF4) and high (e.g., von Willebrand factor) molecular mass. Of the 81 proteins observed in two or three repeat experiments, thirty (37%) are known to be released from platelets including multimerin, thrombospondin and PF4. Integral membrane proteins, such as IIb and known signalling proteins were not represented, suggesting that the identified fraction is relatively specific and enriched for secreted and exosomal proteins.
Fifty-one (63%) of the proteins identified were not known to be released from platelets. A possible explanation for the presence of these proteins is contamination of the releasate with intracellular platelet proteins released by platelet lysis. However, the absence of major signalling proteins argues against this. Furthermore, twenty-eight (35%) of the identified proteins are proteins that are released by other secretory cells ( Three proteins, SgIII, cyclophilin A, and calumenin, not previously recognized to be present in or released by platelets, were examined further as they are of potential interest in the pathogenesis of atherosclerosis. These three proteins were localised to platelets by western blotting, confocal microscopy, flow cytometry and, for cyclophilin A and calumenin, by microarray analysis of mRNA. While absent from normal artery, these three proteins were found in human atherosclerotic plaque. These lesions also stained for CD41 and PF4, two SgIII is a member of the chromogranin family of acidic secretory proteins, previously shown only to be localized to storage vesicles of neuronal and endocrine cells 54, 55 . Secreteogranin II, a close homolog also found in our platelet releasate (n=1; see supplementary data), is present in neuroendocrine storage vesicles, and is the precursor of the neuropeptide secretoneurin, which has a tissue distribution and function similar to the proinflammatory neuropeptides, substance P and neuropeptide Y. Secretoneurin stimulates monocyte adhesion to the vessel wall followed by their trans-endothelial migration 56 . Whether cleavage products of SgIII play a similar role is unknown.
Cyclophilins are peptidyl-propyl cis-trans-isomerases that act intracellularly both as catalysts The third protein, calumenin, belongs to the CREC family of calcium binding proteins and was recently found to be secreted from early melanosomes, which are closely related to platelet dense granules 59 . Calumenin has a chaperone function in the endoplasmic reticulum, but little is known about its extracellular function 60 . It has however, been shown to bind to serum amyloid P component, which is also released from platelets ( only.
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